Science and engineering

Novartis and UC Berkeley collaborate to tackle 'undruggable' disease targets

Currently, only an autopsy can detect the progressive degenerative brain disease CTE, which affects people with a history of repeated head trauma.

Raising the legal age to buy tobacco in the United States to 21 could save more than 300,000 lives, a new web-based tool suggests.

The remote data storage business is booming, for companies and hackers alike

Observing the unusually comet-like asteroid 288P gave astronomers a surprise: It's actually two asteroids that act like a comet.

On September 25, FUJIFILM Corporation (President: Kenji Sukeno) invested ¥430 million in the regenerative medicine venture company NC Medical Research, Inc. with NC Medical granting Fujifilm a stock allocation

MIT spinout prepares to launch line of wristbands that keep wearers thermally comfortable.

Galapagos NV and MorphoSys AG today announced Phase 1 results with their joint investigational antibody program MOR106 directed against IL-17C in patients with moderate-to-severe atopic dermatitis

Trimble Introduces New Version of eCognition Software Suite with Powerful New Geospatial Data Analysis Capabilities.

Kuros Biosciences Reports Financial Results for First Half-Year of 2017

Newron raises CHF 27.0 Million in a private placement of new shares

NVIDIA today announced that China's leading original equipment manufacturers (OEMs) -- including Huawei, Inspur and Lenovo -- are using the NVIDIA® HGX reference architecture to offer Volta architecture-based accelerated systems for hyperscale data centers.

Engineered insulin that can be activated by high blood sugar could improve diabetics’ quality of life.

Today Mastercard and Swarovski launched a virtual reality (VR) shopping app for the Atelier Swarovski home décor line, a collection of functional and decorative crystal home accessories designed in collaboration with world-renowned architects and designers

GE Healthcare introduces a new Protein A chromatography resin, MabSelect PrismA, which will help biopharmaceutical manufacturers improve their monoclonal antibody (mAb) purification capacity by up to 40 percent.